Organon Acquired by Sun Pharma | Healthcare M&A Deal

Sun Pharma has acquired Organon, a pharmacy business in New Jersey, for $11.75 billion enterprise valuation. Sun Pharma acquisitions are focused on expanding healthcare M&A capabilities, and Organon is a global healthcare company with a women’s health portfolio spanning more than 70 products across Women’s Health and General Medicines, including biosimilars, sold across 140 countries. The Sun Pharma acquires Organon strategy combines complementary portfolios and global scale to strengthen commercial reach in key markets including the U.S., Europe, China, Canada, and Brazil. The merger acquisition is an all-cash strategic acquisition with Organon stockholders receiving $14.00 per share, and it is currently announced with a definitive agreement in place.